STRS Ohio’s Arcus Biosciences RCUS Stock Holding History

STRS Ohio’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$363K	Hold	16,800	–	–	﹤0.01%	1244
2025 Q4	$400K	Buy	+16,800	New	+$343K	﹤0.01%	1184
2025 Q2	–	Sell	-8,500	Closed	-$66.7K	–	2289
2025 Q1	$66.7K	Hold	8,500	–	–	﹤0.01%	1735
2024 Q4	$127K	Hold	8,500	–	–	﹤0.01%	1600
2024 Q3	$130K	Buy	8,500 +1,600	+23%	+$25.2K	﹤0.01%	1657
2024 Q2	$105K	Buy	+6,900	New	+$111K	﹤0.01%	1693
2024 Q1	–	Sell	-8,300	Closed	-$158K	–	2017
2023 Q4	$158K	Buy	8,300 +5,900	+246%	+$94.3K	﹤0.01%	1624
2023 Q3	$43K	Buy	+2,400	New	+$48.2K	﹤0.01%	1807
2023 Q2	–	Sell	-22,600	Closed	-$412K	–	2070
2023 Q1	$412K	Sell	22,600 -3,500	-13%	-$66.9K	﹤0.01%	1402
2022 Q4	$539K	Sell	26,100 -6,500	-20%	-$179K	﹤0.01%	1282
2022 Q3	$852K	Sell	32,600 -1,700	-5%	-$45K	﹤0.01%	993
2022 Q2	$869K	Buy	+34,300	New	+$840K	﹤0.01%	1005
2021 Q4	–	Sell	-16,400	Closed	-$571K	–	2286
2021 Q3	$571K	Hold	16,400	–	–	﹤0.01%	1459
2021 Q2	$450K	Buy	16,400 +4,500	+38%	+$129K	﹤0.01%	1595
2021 Q1	$334K	Sell	11,900 -6,900	-37%	-$240K	﹤0.01%	1687
2020 Q4	$488K	Buy	18,800 +6,000	+47%	+$145K	﹤0.01%	1485
2020 Q3	$219K	Sell	12,800 -500	-4%	-$11.2K	﹤0.01%	1644
2020 Q2	$329K	Buy	+13,300	New	+$359K	﹤0.01%	1499
2018 Q3	–	Sell	-1,500	Closed	-$19.1K	–	2168
2018 Q2	$18K	Buy	+1,500	New	+$23.5K	﹤0.01%	2062

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

STRS Ohio's RCUS Position: Q1 2026 in Review

STRS Ohio held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 16,800 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

STRS Ohio first reported a position in RCUS in Q2 2018 and has held it in 19 quarters since. The position peaked at $869K in Q2 2022. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

STRS Ohio held 16,800 shares of Arcus Biosciences worth $363K as of Q1 2026.
STRS Ohio left its Arcus Biosciences share count unchanged in Q1 2026.
Arcus Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1244 holding.
STRS Ohio first reported a position in Arcus Biosciences in Q2 2018 and has held it in 19 quarters since.
STRS Ohio's Arcus Biosciences position peaked at $869K in Q2 2022.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.